Press Release – Green Shoots Consulting

Verge Genomics Secures $98 Million in New Financing

SOURCE: Verge Genomics, BUSINESS WIRE December 16, 2021 06:30 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Verge Genomics, a tech-enabled drug discovery company pioneering the use of artificial intelligence (AI) and human data to develop new drugs, announced today it has closed an oversubscribed $98 million equity financing. The Series B financing was led by funds […]

7 months ago

Green Shoots Consulting, LLC Co-Sponsors White Paper on Real-World Evidence Ecosystem

An evolution of medical diagnostics, treatments, and services relies upon trusted vendors collectively developing “Digital DNA” – scaled medical datasets, diverse provider networks, and cutting-edge software applications STUART, Fla., Sept. 30, 2021 /PRNewswire/ — A new white paper co-sponsored by Green Shoots Consulting, LLC offers a unique lens into the emerging confluence of health care subsectors […]

9 months ago

McDermott Represents MERCK GHI in its investment in M2GEN

SOURCE: McDermott Will & Emery NEW YORK, March 23, 2021 /mwe.com/ — New York: International law firm McDermott Will & Emery represented Merck Global Health Innovation Fund (Merck GHI), a corporate healthcare venture capital fund, in its investment to recapitalize M2GEN, a leading oncology data and informatics platform focused on transforming cancer care. Clayton, Dubilier & […]

1 year ago

CD&R, Merck GHI, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Company M2GEN

SOURCE: M2GEN, PRNewswire TAMPA, Fla. and NEW YORK, March 17, 2021 /PRNewswire/ — M2GEN today announced a significant new investment by Clayton, Dubilier & Rice (“CD&R”) funds, the Merck Global Health Innovation Fund (“Merck GHI”), and McKesson Ventures to recapitalize M2GEN, a leading oncology data and informatics platform focused on transforming cancer care, in partnership […]

1 year ago